$华大基因(SZ300676)$   Item 8.01 Other Events.

On May 6, 2022, a jury in the U.S. District Court for the District of Delaware rendered a verdict that Illumina, Inc. (the “Company”) willfully infringed U.S. Patent Nos. 9,222,132 and 10,662,473 owned by Complete Genomics, Inc. (“CGI”), and awarded approximately $334 million to CGI in past damages. The jury also invalidated three patents owned by the Company, namely, U.S. Patent Nos. 9,217,178; 9,303,290; and 9,970,055. The Company disagrees with the jury’s verdict and intends to vigorously defend the action, including filing all appropriate appeals. If our appeals are unsuccessful, we could be required to pay interest on the judgment and an ongoing royalty at a rate to be determined by the court until the patents expire in January 2029. In addition, although CGI may seek an injunction, we do not believe there is a reasonable basis for the court to grant one.

Item 9.01 Financial Statements and Exhibits.